Need help finding what you are looking for?
Contact Us
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1290832
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1290832
Benign Prostatic Hyperplasia Treatment Market with COVID-19 Impact Analysis, By Product Type, By Application, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
PUBLISHED:
PAGES: 354 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
REPORT HIGHLIGHT
Benign Prostatic Hyperplasia Treatment Market size was valued at USD 11,005.4 million in 2022, expanding at a CAGR of 5.9% from 2023 to 2030.
Benign prostatic hyperplasia, a noncancerous enlargement of the prostate gland, is the most common benign tumor found in men. Many treatments are available for enlarged prostate. These include medicines, surgery, and procedures that involve smaller, fewer, or no cuts. Furthermore, New BPH treatments are less invasive and damaging to healthy tissue than surgery. In general, most of these treatments are outpatient procedures, which means consumers can go home the same day as the procedure. They're also cheaper, have fewer side effects and allow for a faster recovery.
Benign Prostatic Hyperplasia Treatment Market- Market Dynamics
The growth of the benign prostatic hyperplasia therapeutics market is majorly driven due to the rise in the prevalence of benign prostatic hyperplasia.
The global population urging the burden of age-associated diseases, such as benign prostatic hyperplasia, has become a global health priority. Benign prostatic hyperplasia is a common urological disease among older men. The age-specific prevalence of benign prostatic hyperplasia has been estimated from autopsy evaluations to be 8% in the fourth decade of life, 50% in the sixth decade of life, and 80% in the ninth decade of life. The burden of benign prostatic hyperplasia is rising throughout the world, primarily due to population growth and aging. Overall, the growth of the benign prostatic hyperplasia therapeutics market is majorly driven due to the rise in the prevalence of benign prostatic hyperplasia as well as the rise in urological illnesses linked with benign prostatic hyperplasia.
Benign Prostatic Hyperplasia Treatment Market- Key Insights
- As per the analysis shared by our research analyst, the global Benign Prostatic Hyperplasia Treatment market is estimated to grow annually at a CAGR of around 5.5.% over the forecast period (2023-2030)
- The Benign Prostatic Hyperplasia Treatment industry is projected to grow at a significant rate due to the growing awareness of sustainable growth
- Based on Product type segmentation, Drug treatment was predicted to show maximum market share in the year 2022
- Based on Application segmentation, Home healthcare was the leading type in 2022
- On the basis of region, North America was the leading revenue generator in 2022
Benign Prostatic Hyperplasia Treatment Market- Segmentation Analysis:
The Global Benign Prostatic Hyperplasia Treatment Market is segmented on the basis of Product Type, Application, Technology, and Region.
The market is divided into three categories based on product type: Drug treatment, Minimally Invasive Surgeries, laser therapy, and others. Drug treatment dominates the market due to providing symptom relief and facilitating prevent the progression of BPH.
The market is divided into four categories based on application: Hospitals, Ambulatory Surgical Centers, Specialty Clinics, home healthcare, and Others. Home healthcare dominates the market and is likely to maintain its dominance during the forecast period. Patients should also continue taking their prescriptions for a few weeks after surgery. As a result, in his market, the emphasis is biased toward home healthcare rather than hospital care.
Benign Prostatic Hyperplasia Treatment Market- Geographical Insights
Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. North America is expected to dominate the growth of the Benign Prostatic Hyperplasia Treatment market, due to the increasing geriatric population, and rising awareness among the general public about the available treatment options. According to American Community Survey (ACS) Data Users Group, the number of Americans ages 65 and older is projected to nearly double from 52 million in 2018 to 95 million by 2060, and the 65-and-older age group's share of the total population will rise from 16 percent to 23 percent. The Benign Prostatic Hyperplasia Treatment market is influenced by different market drivers and end-user industries across different regions. Companies in the Benign Prostatic Hyperplasia Treatment market develop specialized solutions to meet the specific needs of customers in each region like Europe, Asia pacific, Latin America, the Middle East & Africa, etc.
Benign Prostatic Hyperplasia Treatment Market- Competitive Landscape:
Some of the primary techniques used by corporations to strengthen their reach and expand their market share include new product launches, distribution network development, R&D spending, and mergers and acquisitions. Each of these companies provides different treatment options and technologies, and the choice of treatment depends on factors such as the patient's condition, preferences, and the expertise of the healthcare provider. It's crucial to consult with a urologist or healthcare professional who can assess specific cases and recommend the most appropriate treatment approach. For example, Boston Scientific Corporation recently announced that it has purchased technology for treating symptomatic benign prostatic hyperplasia from Celsion Corporation, following approval of the acquisition by Celsion stockholders at the company's annual meeting on June 13.
Recent Developments:
In 2022, Olympus, a global technology leader in designing and delivering innovative medical technology solutions, announced nowadays the first commercial treatment of Benign Prostatic Hyperplasia (BPH) in Canada using the minimally invasive iTind procedure.
Key features of the study:
- This proposed research study on Benign Prostatic Hyperplasia Treatment market provides market size (US$ million), compound annual growth rate (CAGR %) and forecast estimation (2023-2030), considering 2022 as the base year
- The report provides the client the latest up-to-date and trending insights about the Benign Prostatic Hyperplasia Treatment market.
- The research report elucidates potential growth opportunities across different segments/countries and explains attractive investment proposition matrix for Benign Prostatic Hyperplasia Treatment market
- The overall report identifies new investment opportunities, challenges faced by established players, and growth factors to sustain in the Benign Prostatic Hyperplasia Treatment market
- Impact of COVID-19 on Benign Prostatic Hyperplasia Treatment market size, forecast, CAGR, and market dynamics are discussed in detail under the research scope. Detailed insight on Benign Prostatic Hyperplasia Treatment market post-COVID will also be covered.
- In order to give the users of this report a comprehensive view on the Benign Prostatic Hyperplasia Treatment market, we have also included competitive landscape and key innovator analysis for the Benign Prostatic Hyperplasia Treatment market.
- The study encompasses a growth prospect mapping analysis, wherein all the industry segments are benchmarked based on their market size, growth rate and attractiveness.
- The report offers detailed company profiling featuring major market participants which will help users to understand their financial information and strategic initiatives of players operating in the Benign Prostatic Hyperplasia Treatment market.
- In addition, the report also unveil the important acquisitions & mergers, collaborations & joint ventures, new launch, research & development, regional expansion of major participants involved in the market on global as well as regional level.
- The global Benign Prostatic Hyperplasia Treatment market report primarily caters to various stakeholders in this industry including suppliers, investors, new entrants, distributors, and financial analysts
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL BENIGN PROSTATIC HYPERPLASIA TREATMENT MARKET KEY PLAYERS
- Boston Scientific Corporation
- Teleflex Incorporated
- Endo International plc
- Urologix, LLC
- LISA Laser
- Olympus Corporation
- Other
GLOBAL BENIGN PROSTATIC HYPERPLASIA TREATMENT MARKET, BY PRODUCT TYPE
- Drug Treatment
- Alpha-blockers
- 5-Alpha-reductase Inhibitor (5-ARIs)
- Phosphodiesterase-5 Enzyme Inhibitor
- Others
- Minimally Invasive Surgeries
- Transurethral Resection of the Prostate (TURP)
- Transurethral Incision of the Prostate (TUIP)
- Robotic Surgeries
- Transurethral Microwave Thermotherapy (TUMT)
- Prostatic Urethral Lift
- Others
- Laser Therapy
- Others
GLOBAL BENIGN PROSTATIC HYPERPLASIA TREATMENT MARKET, BY APPLICATION
- Hospitals
- Ambulatory Surgical Centers
- Specialty Clinics
- Home healthcare
- Others
GLOBAL BENIGN PROSTATIC HYPERPLASIA TREATMENT MARKET, BY REGION
- North America
- The U.S.
- Canada
- Europe
- Germany
- France
- Italy
- Spain
- United Kingdom
- Russia
- Netherlands
- Sweden
- Poland
- Rest of Europe
- Asia Pacific
- India
- China
- South Korea
- Japan
- Australia
- Thailand
- Indonesia
- Philippines
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
- The Middle East and Africa
- Saudi Arabia
- United Arab Emirates
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
Product Code: ANV1307
TABLE OF CONTENT
1. Benign Prostatic Hyperplasia Treatment Market Overview
- 1.1. Study Scope
2. Executive Summary
- 2.1. Market Snippet
- 2.1.1. Benign Prostatic Hyperplasia Treatment Market Snippet by Product Type
- 2.1.2. Benign Prostatic Hyperplasia Treatment Market Snippet by Application
- 2.1.3. Benign Prostatic Hyperplasia Treatment Market Snippet by Country
- 2.1.4. Benign Prostatic Hyperplasia Treatment Market Snippet by Region
- 2.2. Competitive Insights
3. Benign Prostatic Hyperplasia Treatment Key Market Trends
- 3.1. Benign Prostatic Hyperplasia Treatment Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
- 3.2. Benign Prostatic Hyperplasia Treatment Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
- 3.3. Benign Prostatic Hyperplasia Treatment Market Opportunities
- 3.4. Benign Prostatic Hyperplasia Treatment Market Future Trends
4. Benign Prostatic Hyperplasia Treatment Industry Study
- 4.1. PEST Analysis
- 4.2. Porter's Five Forces Analysis
- 4.3. Growth Prospect Mapping
- 4.4. Regulatory Framework Analysis
5. Benign Prostatic Hyperplasia Treatment Market: COVID-19 Impact Analysis
- 5.1. Pre-COVID-19 Impact Analysis
- 5.2. Post-COVID-19 Impact Analysis
- 5.2.1. Top Performing Segments
- 5.2.2. Marginal Growth Segments
- 5.2.3. Top Looser Segments
- 5.2.4. Marginal Loss Segments
6. Benign Prostatic Hyperplasia Treatment Market Landscape
- 6.1. Benign Prostatic Hyperplasia Treatment Market Share Analysis, 2022
- 6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis
7. Benign Prostatic Hyperplasia Treatment Market - By Product Type
- 7.1. Overview
- 7.1.1. Segment Share Analysis, By Product Type, 2022 & 2030 (%)
- 7.1.2. Drug Treatment
- 7.1.3. Minimally Invasive Surgeries
- 7.1.4. Laser Therapy
- 7.1.5. Others
8. Benign Prostatic Hyperplasia Treatment Market - By Application
- 8.1. Overview
- 8.1.1. Segment Share Analysis, By Application, 2022 & 2030 (%)
- 8.1.2. Hospitals
- 8.1.3. Ambulatory Surgical Centers
- 8.1.4. Specialty Clinics
- 8.1.5. Home healthcare
- 8.1.6. Others
9. Benign Prostatic Hyperplasia Treatment Market- By Geography
- 9.1. Introduction
- 9.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
- 9.2. North America
- 9.2.1. Overview
- 9.2.2. Benign Prostatic Hyperplasia Treatment Key Manufacturers in North America
- 9.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 9.2.4. North America Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
- 9.2.5. North America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.2.6. U.S.
- 9.2.6.1. Overview
- 9.2.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.2.6.3. U.S. Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
- 9.2.6.4. U.S. Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.2.7. Canada
- 9.2.7.1. Overview
- 9.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.2.7.3. Canada Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
- 9.2.7.4. Canada Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.3. Europe
- 9.3.1. Overview
- 9.3.2. Benign Prostatic Hyperplasia Treatment Key Manufacturers in Europe
- 9.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 9.3.4. Europe Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
- 9.3.5. Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.3.6. Germany
- 9.3.6.1. Overview
- 9.3.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.3.6.3. Germany Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
- 9.3.6.4. Germany Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.3.7. Italy
- 9.3.7.1. Overview
- 9.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.3.7.3. Italy Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
- 9.3.7.4. Italy Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.3.8. United Kingdom
- 9.3.8.1. Overview
- 9.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.3.8.3. United Kingdom Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
- 9.3.8.4. United Kingdom Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.3.9. France
- 9.3.9.1. Overview
- 9.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.3.9.3. France Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
- 9.3.9.4. France Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.3.10. Russia
- 9.3.10.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.3.10.2. Russia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
- 9.3.10.3. Russia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.3.11. Netherlands
- 9.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.3.11.2. Netherlands Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
- 9.3.11.3. Netherlands Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.3.12. Sweden
- 9.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.3.12.2. Sweden Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
- 9.3.12.3. Sweden Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.3.13. Poland
- 9.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.3.13.2. Poland Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
- 9.3.13.3. Poland Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.3.14. Rest of Europe
- 9.3.14.1. Overview
- 9.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.3.14.3. Rest of the Europe Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
- 9.3.14.4. Rest of the Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.4. Asia Pacific (APAC)
- 9.4.1. Overview
- 9.4.2. Benign Prostatic Hyperplasia Treatment Key Manufacturers in Asia Pacific
- 9.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 9.4.4. Asia Pacific Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
- 9.4.5. Asia Pacific Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.4.6. India
- 9.4.6.1. Overview
- 9.4.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.4.6.3. India Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
- 9.4.6.4. India Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.4.7. China
- 9.4.7.1. Overview
- 9.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.4.7.3. China Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
- 9.4.7.4. China Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.4.8. Japan
- 9.4.8.1. Overview
- 9.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.4.8.3. Japan Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
- 9.4.8.4. Japan Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.4.9. South Korea
- 9.4.9.1. Overview
- 9.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.4.9.3. South Korea Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
- 9.4.9.4. South Korea Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.4.10. Australia
- 9.4.10.1. Overview
- 9.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.4.10.3. Australia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
- 9.4.10.4. Australia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.4.11. Thailand
- 9.4.11.1. Overview
- 9.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.4.11.3. Thailand Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
- 9.4.11.4. Thailand Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.4.12. Indonesia
- 9.4.12.1. Overview
- 9.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.4.12.3. Indonesia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
- 9.4.12.4. Indonesia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.4.13. Philippines
- 9.4.13.1. Overview
- 9.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.4.13.3. Philippines Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
- 9.4.13.4. Philippines Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.4.14. Rest of APAC
- 9.4.14.1. Overview
- 9.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.4.14.3. Rest of APAC Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
- 9.4.14.4. Rest of APAC Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.5. Latin America
- 9.5.1. Overview
- 9.5.2. Benign Prostatic Hyperplasia Treatment Key Manufacturers in Latin America
- 9.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 9.5.4. Latin America Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
- 9.5.5. Latin America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.5.6. Brazil
- 9.5.6.1. Overview
- 9.5.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.5.6.3. Brazil Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
- 9.5.6.4. Brazil Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.5.7. Mexico
- 9.5.7.1. Overview
- 9.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.5.7.3. Mexico Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
- 9.5.7.4. Mexico Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.5.8. Argentina
- 9.5.8.1. Overview
- 9.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.5.8.3. Argentina Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
- 9.5.8.4. Argentina Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.5.9. Colombia
- 9.5.9.1. Overview
- 9.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.5.9.3. Colombia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
- 9.5.9.4. Colombia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.5.10. Rest of LATAM
- 9.5.10.1. Overview
- 9.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.5.10.3. Rest of LATAM Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
- 9.5.10.4. Rest of LATAM Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.6. Middle East and Africa
- 9.6.1. Overview
- 9.6.2. Benign Prostatic Hyperplasia Treatment Key Manufacturers in Middle East and Africa
- 9.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 9.6.4. Middle East and Africa Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
- 9.6.5. Middle East and Africa Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.6.6. Saudi Arabia
- 9.6.6.1. Overview
- 9.6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.6.6.3. Saudi Arabia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
- 9.6.6.4. Saudi Arabia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.6.7. United Arab Emirates
- 9.6.7.1. Overview
- 9.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.6.7.3. United Arab Emirates Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
- 9.6.7.4. United Arab Emirates Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.6.8. Israel
- 9.6.8.1. Overview
- 9.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.6.8.3. Israel Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
- 9.6.8.4. Israel Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.6.9. Turkey
- 9.6.9.1. Overview
- 9.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.6.9.3. Turkey Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
- 9.6.9.4. Turkey Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.6.10. Algeria
- 9.6.10.1. Overview
- 9.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.6.10.3. Algeria Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
- 9.6.10.4. Algeria Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.6.11. Egypt
- 9.6.11.1. Overview
- 9.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.6.11.3. Egypt Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
- 9.6.11.4. Egypt Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 9.6.12. Rest of MEA
- 9.6.12.1. Overview
- 9.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.6.12.3. Rest of MEA Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
- 9.6.12.4. Rest of MEA Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10. Key Vendor Analysis- Benign Prostatic Hyperplasia Treatment Industry
- 10.1. Competitive Dashboard
- 10.2. Company Profiles
- 10.2.1. Carrier
- 10.2.2. Daikin Industries, Ltd
- 10.2.3. NIBE GroupViessmann Group
- 10.2.4. Glen Dimplex
- 10.2.5. BDR Thermea Group
- 10.2.6. Midea Group
- 10.2.7. Hitachi, Ltd.
- 10.2.8. Ingersoll Rand Plc.
- 10.2.9. STIEBEL ELTRON GmbH & Co. KG
- 10.2.10. Vaillant Group
- 10.2.11. Robert Bosch GmbH
- 10.2.12. The Danfoss Group
11. 360 Degree Analyst View
12. Appendix
- 12.1. Research Methodology
- 12.2. References
- 12.3. Abbreviations
- 12.4. Disclaimer
- 12.5. Contact Us
Product Code: ANV1307
List of Tables
- TABLE List of data sources
- TABLE Market drivers; Impact Analysis
- TABLE Market restraints; Impact Analysis
- TABLE Benign Prostatic Hyperplasia Treatment Market: Product Type Snapshot (2022)
- TABLE Segment Dashboard; Definition and Scope, by Product Type
- TABLE Global Benign Prostatic Hyperplasia Treatment Market, by Product Type 2018-2030 (USD Million)
- TABLE Benign Prostatic Hyperplasia Treatment Market: Application Snapshot (2022)
- TABLE Segment Dashboard; Definition and Scope, by Application
- TABLE Global Benign Prostatic Hyperplasia Treatment Market, by Application 2018-2030 (USD Million)
- TABLE Benign Prostatic Hyperplasia Treatment Market: Regional snapshot (2022)
- TABLE Segment Dashboard; Definition and Scope, by Region
- TABLE Global Benign Prostatic Hyperplasia Treatment Market, by Region 2018-2030 (USD Million)
- TABLE North America Benign Prostatic Hyperplasia Treatment Market, by Country, 2018-2030 (USD Million)
- TABLE North America Benign Prostatic Hyperplasia Treatment Market, by Product Type, 2018-2030 (USD Million)
- TABLE North America Benign Prostatic Hyperplasia Treatment Market, by Application, 2018-2030 (USD Million)
- TABLE Europe Benign Prostatic Hyperplasia Treatment Market, by Country, 2018-2030 (USD Million)
- TABLE Europe Benign Prostatic Hyperplasia Treatment Market, by Product Type, 2018-2030 (USD Million)
- TABLE Europe Benign Prostatic Hyperplasia Treatment Market, by Application, 2018-2030 (USD Million)
- TABLE Asia Pacific Benign Prostatic Hyperplasia Treatment Market, by Country, 2018-2030 (USD Million)
- TABLE Asia Pacific Benign Prostatic Hyperplasia Treatment Market, by Product Type, 2018-2030 (USD Million)
- TABLE Asia Pacific Benign Prostatic Hyperplasia Treatment Market, by Application, 2018-2030 (USD Million)
- TABLE Latin America Benign Prostatic Hyperplasia Treatment Market, by Country, 2018-2030 (USD Million)
- TABLE Latin America Benign Prostatic Hyperplasia Treatment Market, by Product Type, 2018-2030 (USD Million)
- TABLE Latin America Benign Prostatic Hyperplasia Treatment Market, by Application, 2018-2030 (USD Million)
- TABLE Middle East and Africa Benign Prostatic Hyperplasia Treatment Market, by Country, 2018-2030 (USD Million)
- TABLE Middle East and Africa Benign Prostatic Hyperplasia Treatment Market, by Product Type, 2018-2030 (USD Million)
- TABLE Middle East and Africa Benign Prostatic Hyperplasia Treatment Market, by Application, 2018-2030 (USD Million)
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.